(4R)-8-[8-(2,3-dichlorophenyl)sulfanylimidazo[1,2-c]pyrimidin-5-yl]-1-oxa-8-azaspiro[4.5]decan-4-amine
C20H21Cl2N5OS — CID 139427506
Data last refreshed: (MolForge compound catalog, from PubChem)
About (4R)-8-[8-(2,3-dichlorophenyl)sulfanylimidazo[1,2-c]pyrimidin-5-yl]-1-oxa-8-azaspiro[4.5]decan-4-amine
(4R)-8-[8-(2,3-dichlorophenyl)sulfanylimidazo[1,2-c]pyrimidin-5-yl]-1-oxa-8-azaspiro[4.5]decan-4-amine (PubChem CID 139427506) has the molecular formula C20H21Cl2N5OS and a molecular weight of 450.40 g/mol. Its IUPAC name is (4R)-8-[8-(2,3-dichlorophenyl)sulfanylimidazo[1,2-c]pyrimidin-5-yl]-1-oxa-8-azaspiro[4.5]decan-4-amine.
Molecular Properties
| Compound Name | (4R)-8-[8-(2,3-dichlorophenyl)sulfanylimidazo[1,2-c]pyrimidin-5-yl]-1-oxa-8-azaspiro[4.5]decan-4-amine |
|---|---|
| PubChem CID | 139427506 |
| Molecular Formula | C20H21Cl2N5OS |
| Molecular Weight | 450.40 g/mol |
| Exact Mass | 449.08 |
| IUPAC Name | (4R)-8-[8-(2,3-dichlorophenyl)sulfanylimidazo[1,2-c]pyrimidin-5-yl]-1-oxa-8-azaspiro[4.5]decan-4-amine |
| SMILES | N[C@@H]1CCOC12CCN(c1ncc(Sc3cccc(Cl)c3Cl)c3nccn13)CC2 |
| InChI | InChI=1S/C20H21Cl2N5OS/c21-13-2-1-3-14(17(13)22)29-15-12-25-19(27-10-7-24-18(15)27)26-8-5-20(6-9-26)16(23)4-11-28-20/h1-3,7,10,12,16H,4-6,8-9,11,23H2/t16-/m1/s1 |
| InChIKey | UHMWHTNTVCLHHJ-MRXNPFEDSA-N |
| XLogP | 4.27 |
| TPSA | 68.68 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 450.40 |
| LogP ≤ 5 | 4.27 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 139427506 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.